Eurogin is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Informa

Abstract Submission is open! Submit by October 15, 2023

SUBMIT AN ABSTRACT
Open main menu

What is EUROGIN

The Leading International Multidisciplinary HPV Congress

EUROGIN

Started in 1993 as a conference where scientific progress and clinical practice converge, EUROGIN shares translational research with an international scientific community aiming at accelerating the reduction of the burden of HPV-related cancers and their mortality.

In cooperation with a substantial number of highly recognized research groups, the EUROGIN 2024 conference draws up an inventory of recent scientific research to provide healthcare workers and decision-makers with a comprehensive strategy to fight diseases related to human papillomavirus.

The conference focuses on translating scientific and evidence-based research into clinical practice.

Why attend EUROGIN?

EUROGIN translates HPV research into clinical practice

World-class Experts


Our scientific sessions and training courses are delivered by only the best speakers from the academic sector, professionals, and patients of organisations who are at the forefront of HPV research and its associated diseases. 

Scientific Program


The EUROGIN program takes an educational approach for translational research in human papilloma virus and its related diseases. Sessions also advocate for evidence-based policies that improve public health care services. 

Specialized Workshops


We offer specialized training courses and clinical workshops to substantiate your theoretical learning. These include sessions in French as well as workshops on vulvar diseases, colposcopy, anal diseases, head and neck forum & more.  

Networking


As an in-person International Multidisciplinary HPV conference, EUROGIN facilitates the exchange of ideas and is an ideal place to reconnect with you peers as well as interact with leading experts in this field. 

Registration opening soon

STAY TUNED STAY TUNED

Who should attend EUROGIN?

EUROGIN is for clinicians, researchers, scientists, and professionals who specialize in HPV and its related diseases looking to get the latest update on developments in this field.

Clinicians from several disciplines

Including gynecologists, otorhinolaryngologists / head & neck specialists, proctologists, GPs, dermatologists, gastroenterologists,  otorhinolaryngologists, virologists, cytopathologists, oncologists
See all specialties
Close

Cytopathologists - Biologists

Students, residents and young researchers

Basic scientists - Epidemiologists

Health communication specialists

Healthcare decision markers

Governmental and non-governmental institutions

2023 POST MEETING REPORT 2023 POST MEETING REPORT

Scientific Program


EUROGIN offers a full overview of current scientific developments in the field of cervical cancer and other HPV related diseases. 

The program features a forum for high-level scientific exchange involving multiple disciplines, with the aim of translating research into clinical practice. Scientific sessions, clinical workshops, HPV and Head & Neck Forum, among other sessions, offer the latest research.

PROGRAM HIGHLIGHTS

Program Committee

Scientific Committee Chairman

Joseph Monsonego

France

Congress
President

Hans Berkhof

Netherlands

Congress
President

Miriam Elfström

Sweden

SEE FULL PROGRAM COMMITTEE SEE FULL PROGRAM COMMITTEE

Sign up to our Newsletter

Let’s stay in touch! Sign-up to receive updates on our upcoming program, speakers, workshops, and more. 

KEEP ME INFORMED KEEP ME INFORMED

Follow us on social media #Eurogin

Don't miss out on EUROGIN Conference highlights, news, special offers, and much more!

Copyright © 2023. All rights reserved. Informa Markets, a trading division of Informa PLC.